Find Drugs in Development News & Deals for Phosphorylated Hexaacyl Disaccharide

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 5a35gqs15r, 252042-59-4, Phosphorylated hexaacyl disaccharide, [(2r,3s,4r,5r,6r)-2-(hydroxymethyl)-3-phosphonooxy-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]-6-[(2r,3s,4r,5r)-2,3,4-trihydroxy-6-oxo-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]hexoxy]oxan-4-yl] (3r)-3-tetradecanoyloxytetradecanoate, D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-.beta.-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-, D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-beta-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-
Molecular Formula
C96H181N2O21P
Molecular Weight
1730.4  g/mol
InChI Key
UWZZPPFXKHHIMQ-QXFLKPNTSA-N
FDA UNII
5A35GQS15R

Phosphorylated Hexaacyl Disaccharide
1 2D Structure

Phosphorylated Hexaacyl Disaccharide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-3-phosphonooxy-5-[[(3R)-3-tetradecanoyloxytetradecanoyl]amino]-6-[(2R,3S,4R,5R)-2,3,4-trihydroxy-6-oxo-5-[[(3R)-3-tetradecanoyloxytetradecanoyl]amino]hexoxy]oxan-4-yl] (3R)-3-tetradecanoyloxytetradecanoate
2.1.2 InChI
InChI=1S/C96H181N2O21P/c1-7-13-19-25-31-37-40-46-52-58-64-70-87(104)114-79(67-61-55-49-43-34-28-22-16-10-4)73-85(102)97-82(76-99)92(108)93(109)83(101)78-113-96-91(98-86(103)74-80(68-62-56-50-44-35-29-23-17-11-5)115-88(105)71-65-59-53-47-41-38-32-26-20-14-8-2)95(94(84(77-100)117-96)119-120(110,111)112)118-90(107)75-81(69-63-57-51-45-36-30-24-18-12-6)116-89(106)72-66-60-54-48-42-39-33-27-21-15-9-3/h76,79-84,91-96,100-101,108-109H,7-75,77-78H2,1-6H3,(H,97,102)(H,98,103)(H2,110,111,112)/t79-,80-,81-,82+,83-,84-,91-,92-,93-,94-,95-,96-/m1/s1
2.1.3 InChI Key
UWZZPPFXKHHIMQ-QXFLKPNTSA-N
2.1.4 Canonical SMILES
CCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)NC1C(C(C(OC1OCC(C(C(C(C=O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)O)O)O)CO)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC
2.1.5 Isomeric SMILES
CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@H]([C@H]([C@@H]([C@H](C=O)NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)O)O)O)CO)OP(=O)(O)O)OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC
2.2 Other Identifiers
2.2.1 UNII
5A35GQS15R
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 5a35gqs15r

2. 252042-59-4

3. Phosphorylated Hexaacyl Disaccharide

4. [(2r,3s,4r,5r,6r)-2-(hydroxymethyl)-3-phosphonooxy-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]-6-[(2r,3s,4r,5r)-2,3,4-trihydroxy-6-oxo-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]hexoxy]oxan-4-yl] (3r)-3-tetradecanoyloxytetradecanoate

5. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-.beta.-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-

6. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-beta-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-

2.4 Create Date
2020-01-16
3 Chemical and Physical Properties
Molecular Weight 1730.4 g/mol
Molecular Formula C96H181N2O21P
XLogP329.1
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count21
Rotatable Bond Count92
Exact Mass1730.29280262 g/mol
Monoisotopic Mass1729.28944778 g/mol
Topological Polar Surface Area347 Ų
Heavy Atom Count120
Formal Charge0
Complexity2500
Isotope Atom Count0
Defined Atom Stereocenter Count12
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty